Literature DB >> 15152256

A highly active synthetic mammalian retrotransposon.

Jeffrey S Han1, Jef D Boeke.   

Abstract

LINE-1 (L1) elements are retrotransposons that comprise large fractions of mammalian genomes. Transcription through L1 open reading frames is inefficient owing to an elongation defect, inhibiting the robust expression of L1 RNA and proteins, the substrate and enzyme(s) for retrotransposition. This elongation defect probably controls L1 transposition frequency in mammalian cells. Here we report bypassing this transcriptional defect by synthesizing the open reading frames of L1 from synthetic oligonucleotides, altering 24% of the nucleic acid sequence without changing the amino acid sequence. Such resynthesis led to greatly enhanced steady-state L1 RNA and protein levels. Remarkably, when the synthetic open reading frames were substituted for the wild-type open reading frames in an established retrotransposition assay, transposition levels increased more than 200-fold. This indicates that there are probably no large, rigidly conserved cis-acting nucleic acid sequences required for retrotransposition within L1 coding regions. These synthetic retrotransposons are also the most highly active L1 elements known so far and have potential as practical tools for manipulating mammalian genomes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15152256     DOI: 10.1038/nature02535

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  94 in total

1.  Novel transcript truncating function of Rap1p revealed by synthetic codon-optimized Ty1 retrotransposon.

Authors:  Robert M Yarrington; Sarah M Richardson; Cheng Ran Lisa Huang; Jef D Boeke
Journal:  Genetics       Date:  2011-11-30       Impact factor: 4.562

2.  Intact piRNA pathway prevents L1 mobilization in male meiosis.

Authors:  Simon J Newkirk; Suman Lee; Fiorella C Grandi; Valeriya Gaysinskaya; James M Rosser; Nicole Vanden Berg; Cathryn A Hogarth; Maria C N Marchetto; Alysson R Muotri; Michael D Griswold; Ping Ye; Alex Bortvin; Fred H Gage; Jef D Boeke; Wenfeng An
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-19       Impact factor: 11.205

3.  Distinct mechanisms for trans-mediated mobilization of cellular RNAs by the LINE-1 reverse transcriptase.

Authors:  José L Garcia-Perez; Aurélien J Doucet; Alain Bucheton; John V Moran; Nicolas Gilbert
Journal:  Genome Res       Date:  2007-04-06       Impact factor: 9.043

4.  The population genetics of using homing endonuclease genes in vector and pest management.

Authors:  Anne Deredec; Austin Burt; H C J Godfray
Journal:  Genetics       Date:  2008-07-27       Impact factor: 4.562

5.  Teaching synthetic biology, bioinformatics and engineering to undergraduates: the interdisciplinary Build-a-Genome course.

Authors:  Jessica S Dymond; Lisa Z Scheifele; Sarah Richardson; Pablo Lee; Srinivasan Chandrasegaran; Joel S Bader; Jef D Boeke
Journal:  Genetics       Date:  2008-11-17       Impact factor: 4.562

6.  Unconventional translation of mammalian LINE-1 retrotransposons.

Authors:  Reid S Alisch; Jose L Garcia-Perez; Alysson R Muotri; Fred H Gage; John V Moran
Journal:  Genes Dev       Date:  2006-01-15       Impact factor: 11.361

7.  LINE-like retrotransposition in Saccharomyces cerevisiae.

Authors:  Chun Dong; Russell T Poulter; Jeffrey S Han
Journal:  Genetics       Date:  2008-10-28       Impact factor: 4.562

8.  Extensive variation between inbred mouse strains due to endogenous L1 retrotransposition.

Authors:  Keiko Akagi; Jingfeng Li; Robert M Stephens; Natalia Volfovsky; David E Symer
Journal:  Genome Res       Date:  2008-04-01       Impact factor: 9.043

Review 9.  Cancer gene discovery in mouse and man.

Authors:  Jenny Mattison; Louise van der Weyden; Tim Hubbard; David J Adams
Journal:  Biochim Biophys Acta       Date:  2009-03-12

10.  The RNA polymerase dictates ORF1 requirement and timing of LINE and SINE retrotransposition.

Authors:  Emily N Kroutter; Victoria P Belancio; Bradley J Wagstaff; Astrid M Roy-Engel
Journal:  PLoS Genet       Date:  2009-04-24       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.